Clinical Performance and Remineralization Potential of Self- Assembling Peptide P11-4 Containing Fluoride Versus Er, Cr: YSGG Laser Treatment and Micro Tensile Bond Strength of Giomer Restoration in Carious Lesions

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age20-40
SponsorAl-Azhar University

About this trial

This study will be performed in two parts, in vivo and in vitro to assess the effect of the remineralization potential of self-assembling peptide P11-4 containing Fluoride on caries-affected dentin compared to untreated caries-affected dentin and the influence of Er, Cr: YSGG Laser treatment.

Eligibility criteria

Qualifiers

o Patients aged (20 - 40) years.

Presence of at least one posterior permanent molar with an occlusal carious lesion classified as ICDAS code 3 or 4 requiring operative treatment.

Good general and oral health.

Willingness to participate and provide informed consent.

Disqualifiers

o Patients with systemic conditions affecting oral health or healing.

Teeth with pulp involvement or periapical pathology.

Allergy to study materials.

Poor oral hygiene or periodontal disease in the target tooth region.

Trial design

Treatments tested in this trial

  • Curodont Repair Fluoride Plus (Self-assembling peptide remineralization agent)P11-4 peptide, fluoride, mild acidic buffer (pH ~4.5) , Credentis AG, Switzerland
  • Beautifil II LS

Treatment groups

21 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Al-Azhar University

Lead sponsor

Misr University for Science and Technology

Sponsor institution